A fatal respiratory complication of malaria caused by Plasmodium vivax.
Malar J
; 22(1): 303, 2023 Oct 09.
Article
em En
| MEDLINE
| ID: mdl-37814260
ABSTRACT
BACKGROUND:
Malaria is endemic and represents an important public health issue in Brazil. Knowledge of risk factors for disease progression represents an important step in preventing and controlling malaria-related complications. Reports of severe forms of Plasmodium vivax malaria are now becoming a common place, but respiratory complications are described in less than 3% of global literature on severe vivax malaria. CASE PRESENTATION A severe respiratory case of imported vivax malaria in a previously healthy 40-year-old woman has been reported. The patient died after the fifth day of treatment with chloroquine and primaquine due to acute respiratory distress syndrome.CONCLUSIONS:
Respiratory symptoms started 48 h after the initiation of anti-malarial drugs, raising the hypothesis that the drugs may have been involved in the genesis of the complication. The concept that vivax malaria is a benign disease that can sometimes result in the development of serious complications must be disseminated. This report highlights, once more, the crucial importance of malaria early diagnosis, a true challenge in non-endemic areas, where health personnel are not familiar with the disease and do not consider its diagnosis promptly.Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Contexto em Saúde:
2_ODS3
/
3_ND
Base de dados:
MEDLINE
Assunto principal:
Malária Vivax
/
Malária
/
Antimaláricos
Tipo de estudo:
Risk_factors_studies
/
Screening_studies
Limite:
Adult
/
Female
/
Humans
Idioma:
En
Revista:
Malar J
Ano de publicação:
2023
Tipo de documento:
Article